CVRx, Inc. (CVRX) stock
Close on Nov 11, 2026Market cap $18.65MP/E –Yield –
CVRx, Inc. grew revenue 7.8% to $60.33M over the twelve months to Sep 30, 2026. Free cash flow was -$42.05M. At the latest close the market valued the company at $18.65M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $18.65M
- P/E ratio
- –
- Price to sales
- 0.31
- Price to book
- 1.35
- Dividend yield
- –
- Free cash flow yield
- -225.39%
Fundamentals
- Revenue
- $60.33M
- Net income
- -$53.26M
- EPS, diluted
- -$2.01
- Free cash flow
- -$42.05M
- Book value per share
- $0.51
- Diluted shares
- 27M
Trading
- Next earnings
- Feb 11, 2027 (estimated, after the close)
- Previous close
- $0.70
- Open
- $0.72
- Day's range
- $0.70 – $0.74
- Volume
- 377,910
- Average volume (20 days)
- 788,503
- Index membership
- Russell 2000 (since Jun 2023), Russell 3000 (since Aug 2023)
- Beta (5 years)
- 1.16
- 52-week range
- $0.67 – $10.28
- RSI (14 days)
- 22.4
- Volatility (1 year)
- 114.5%
- Relative volume
- 0.44×
- WACC
- 8.9%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CVRX | S&P 500 | Difference | CVRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -55.7% | -2.4% | −53.3 pts | ||
| 3 months | -73.1% | -1.2% | −71.9 pts | ||
| Year to date | -90.1% | +12.3% | −102.4 pts | ||
| 1 year | -92.9% | +12.4% | −105.3 pts | ||
| 3 years | -95.9% | +78.8% | −174.7 pts | -65.5% | +21.4% |
| 5 years | -96.2% | +75.2% | −171.4 pts | -48.1% | +11.9% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases CVRx filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About CVRx
Surgical & Medical Instruments & Apparatus
CVRx is a commercial-stage medical device enterprise that designs, manufactures, and markets minimally invasive neuromodulation therapies for cardiovascular disease. The company's core product is Barostim, an implantable system featuring a pulse generator, a stimulation lead, and a wireless clinician programmer. It operates by delivering electrical pulses to carotid artery baroreceptors to counteract autonomic nervous system imbalances and ease symptoms of heart failure with reduced ejection fraction. Target customers primarily include hospitals, heart failure specialists, cardiologists, and surgeons.
Company profile, executives and historyCVRx stock: common questions
What is CVRx's stock price?
CVRX closed at $0.70 on Nov 11, 2026, up 0.70% on the day. Over the past 52 weeks it traded between $0.67 and $10.28.
What is CVRx's market cap?
CVRx was worth $18.65M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CVRX's P/E ratio?
CVRx lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.01), so it has no meaningful P/E ratio.
How much revenue does CVRx make?
CVRx reported revenue of $60.33M for the twelve months to Sep 30, 2026, up 7.8% from a year earlier.
Does CVRx pay a dividend?
No. CVRx has not paid a cash dividend over the last twelve months.
When does CVRx report earnings next?
CVRx is expected to report Q4 FY2026 results on Feb 11, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has CVRX stock performed over the past year?
Including dividends, CVRX returned -92.9% over the past year, against +12.4% for the S&P 500.
How many CVRX shares are sold short?
2M shares were sold short at the latest FINRA report, 13.59% of the float, or 5.3 days of average trading volume.
Who are CVRx's competitors?
Companies most similar to CVRx by business, industry and size include LUNG, BWAY, OBIO, KMTS, NPCE.
See a number that looks wrong?